Benzinga's Top Initiations - Blueprint Medicines (NASDAQ:BPMC)

Analysts at Loop Capital initiated coverage on Yelp Inc YELP with a Hold rating. Yelp shares rose 0.79 percent to close at $31.93 on Thursday.
Citigroup initiated coverage on SINA Corp SINA with a Buy rating. The price target for SINA is set to $69. SINA shares rose 2.55 percent to close at $55.95 on Thursday.
Analysts at Credit Suisse initiated coverage on Premier Inc PINC with a Outperform rating. The price target for Premier is set to $39. Premier shares dropped 1.19 percent to close at $32.31 on Thursday.
SunTrust Robinson Humphrey initiated coverage of Incyte Corporation INCY with a Buy rating. Incyte shares fell 0.76 percent to close at $90.12 on Thursday.
Analysts at Loop Capital initiated coverage on GrubHub Inc GRUB with a Buy rating. GrubHub shares rose 0.34 percent to close at $38.65 on Thursday.
Analysts at Canaccord Genuity initiated coverage of Blueprint Medicines Corp BPMC with a Buy rating. Blueprint Medicines shares rose 0.78 percent to close at $21.95 on Thursday.
Analysts at Longbow Research initiated coverage on La-Z-Boy Incorporated LZB with a Neutral rating. La-Z-Boy shares rose 0.20 percent to close at $30.04 on Thursday.
Analysts at Barclays assumed coverage on Symantec Corporation SYMC with a Equal-weight rating. The price target for Symantec is set to $24. Symantec shares rose 5.56 percent to $22.20 in pre-market trading.
Analysts at Citigroup initiated coverage on Weibo Corp (ADR) WB with a Buy rating. The price target for Weibo is set to $42. Weibo shares fell 3.57 percent to $32.65 in pre-market trading.

Market News and Data brought to you by Benzinga APIs